Mounjaro and Anaesthesia: What Your Surgical Team Needs to Know

Mounjaro (tirzepatide) slows gastric emptying, which is relevant to anaesthetic risk and fasting protocol planning.
NHS England advises patients to inform their healthcare team, including the anaesthetist, before any surgical procedure.
The decision on whether to pause, continue or adjust timing is made by the surgical and anaesthetic team — not self-managed.
This applies to general and some sedation-based procedures; dental and local anaesthetic situations carry a different profile, discussed below.

If you are taking Mounjaro and have surgery or a procedure involving anaesthesia coming up, the advice is clear: tell your healthcare team, including the anaesthetist, before the date. Tirzepatide slows gastric emptying, which can leave food and fluid in the stomach for longer than usual, and that changes the risk calculation for general anaesthesia. This is an important safety consideration for any prescriber managing your care, and something our clinical team at nume takes seriously. Mounjaro is a prescription-only medicine, assessed and prescribed on an individual basis, so any surgical planning should be done alongside the clinicians who know your full medical picture.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Surgery on Mounjaro: the questions patients and prescribers are working through together

Why does tirzepatide matter to an anaesthetist?

Anaesthetists calculate risk partly around the stomach's contents at the time of a procedure. The standard fasting guidance before general anaesthesia assumes the stomach empties at a predictable rate. Tirzepatide (the active ingredient in Mounjaro) is a dual GIP and GLP-1 receptor agonist that acts on gut motility as part of how it works, slowing the passage of food from the stomach into the small intestine. That effect does not switch off because you followed the usual pre-operative fasting instructions.

In practice, this means there is a real possibility that stomach contents remain present even after a standard fasting period, which creates a risk of regurgitation and aspiration during induction of anaesthesia. Aspiration of gastric contents during a procedure can be serious. Anaesthetic teams are increasingly aware of this risk with all GLP-1 and dual-agonist medicines, and most will want to know you are taking one well before the date of surgery.

NHS England's guidance on weight-management injections advises patients to tell their healthcare team, including the anaesthetist, that they take tirzepatide before any surgical procedure. This is the baseline starting point for every patient on Mounjaro who has a planned operation.

Should you stop Mounjaro before an operation, and if so, when?

This is a question our prescribers hear most weeks, and the honest answer is that there is no single universal rule — the decision belongs to the surgical and anaesthetic team who know the specific procedure, the anaesthetic method being used, and your individual clinical situation.

What the evidence base and professional discussion currently centre on is whether a pause of several weeks before elective surgery, to allow gastric motility to normalise, reduces aspiration risk meaningfully. Some anaesthetic departments have already issued guidance along these lines for elective procedures. Others are assessing on a case-by-case basis. The right course for you depends on how urgent the procedure is, what type of anaesthesia is planned, and whether pausing Mounjaro carries its own clinical risk.

If you are researching this for a planned procedure, the practical step is to raise it at your pre-assessment appointment. If you are on Mounjaro through a private route, it is also worth letting your prescribing service know, a note on your record and a letter to the surgical team can help. You can read more about how tirzepatide works as a medicine on the tirzepatide overview page.

Does the same concern apply to local anaesthesia and dental procedures?

Local anaesthesia, where only a specific area is numbed without any sedation or loss of consciousness, does not carry the same aspiration risk as general anaesthesia. If you are fully alert and your airway reflexes are intact, the gastric-emptying effect of tirzepatide is not directly relevant to the anaesthetic itself.

That said, some dental procedures involve sedation rather than purely local anaesthetic, and sedation sits closer to general anaesthesia in terms of the protective reflex picture. The considerations for Mounjaro and dental anaesthesia are worth exploring separately, because the answer is different depending on whether your dentist is using a local block, conscious sedation or a referral to a hospital setting.

For any procedure involving sedation or general anaesthesia, the same principle applies: disclose that you are taking Mounjaro. The guidance around Mounjaro and general anaesthetic covers what anaesthetic teams are currently advising in more detail. The Mounjaro patient information leaflet, accessible via the eMC (electronic Medicines Compendium), also sets out the prescribing information relevant to your anaesthetic and surgical team.

What about emergency surgery or procedures that cannot be delayed?

Emergency procedures by definition cannot wait for a weeks-long washout period. In that scenario, the anaesthetic team will take additional precautions, a rapid-sequence induction technique, for example, or point-of-care gastric ultrasound to assess stomach contents before proceeding. These are established tools for managing high aspiration risk, and the anaesthetic team managing your emergency care will make the clinical call.

Your job in an emergency is simply to communicate what you are taking as clearly and promptly as possible. If you carry a medicines list, make sure Mounjaro appears on it with the dose. If you are not yet on treatment but are considering starting, the full Mounjaro treatment guide covers eligibility and how the prescribing process works at a regulated UK service.

If surgery is coming up and you have questions about your current treatment plan, cost considerations are sometimes part of that conversation too, the Mounjaro cost overview sets out what private treatment typically involves so you can plan accordingly. Patients pausing treatment ahead of a procedure sometimes also take the opportunity to read about how Mounjaro can affect facial volume and skin appearance, as this is another topic that comes up during longer-term planning conversations. When you are ready to discuss your clinical picture with a prescriber, starting a free consultation with our team is the most direct route.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions